Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Non Operating Income (2023 - 2025)

Historic Non Operating Income for Rallybio (RLYB) over the last 3 years, with Q3 2025 value amounting to $22.9 million.

  • Rallybio's Non Operating Income rose 175456.75% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.4 million, marking a year-over-year increase of 36603.05%. This contributed to the annual value of $5.0 million for FY2024, which is 2260.88% down from last year.
  • Rallybio's Non Operating Income amounted to $22.9 million in Q3 2025, which was up 175456.75% from $641000.0 recorded in Q2 2025.
  • In the past 5 years, Rallybio's Non Operating Income registered a high of $22.9 million during Q3 2025, and its lowest value of $641000.0 during Q2 2025.
  • Over the past 3 years, Rallybio's median Non Operating Income value was $1.4 million (recorded in 2024), while the average stood at $3.3 million.
  • Over the last 5 years, Rallybio's Non Operating Income had its largest YoY gain of 175456.75% in 2025, and its largest YoY loss of 5015.55% in 2025.
  • Over the past 3 years, Rallybio's Non Operating Income (Quarter) stood at $1.5 million in 2023, then crashed by 32.97% to $994000.0 in 2024, then soared by 2207.95% to $22.9 million in 2025.
  • Its Non Operating Income was $22.9 million in Q3 2025, compared to $641000.0 in Q2 2025 and $818000.0 in Q1 2025.